Cherrington lab

Professor Pharmacology and Toxicology, we study MASH, Blood-testis barrier, Adverse drug reaction, Drug metabolism and distribution.

[Cherrington lab @Cherrington_Lab]

New Publication alert! In this paper, we recommend the inclusion of the #ENT #transporters in the #FDA and #EMA guidance for #drugscreening.
https://t.co/1IyhuFGH26

[Cherrington lab @Cherrington_Lab]

Check our our recent publication! Alterations of valsartan pharmacokinetics in MASH https://t.co/b8ACi5fDQP

[Cherrington lab @Cherrington_Lab]

New Publication! Increased plasma retention of sorafenib-glucuronide in MASH. https://t.co/Y2Vw7CuEZ7

[Cherrington lab @Cherrington_Lab]

Congratulations Frost et al! Our paper was chosen by SOT Board of Publications for 2024 Paper of the Year Award. #ToxSci https://t.co/YGKioU3034

[Cherrington lab @Cherrington_Lab]

Congrats to our very own @alaaldinmina, she has been selected to receive an Undergraduate Research Award at the 2024 Annual Meeting of the Society of Toxicology (SOT). #SOT2024

[Cherrington lab @Cherrington_Lab]

Congrats to our very own @paige_lindberg, she has been selected to receive an Undergraduate Research Award at the 2024 Annual Meeting of the Society of Toxicology (SOT). #SOT2024

[Cherrington lab @Cherrington_Lab]

When you present your #seminar you get a lab mascot, say hello to Paco Labguin the #lab #pinguin, thanks to @geneseesci.

[Cherrington lab @Cherrington_Lab]

@JohnStreicher1 Have you tried Moravek?

[Cherrington lab @Cherrington_Lab]

New publication! from our most recent graduate, Raymond Hau

[Cherrington lab @Cherrington_Lab]

New Publication Alert, Rodent models of nonalcoholic steatohepatitis that recapitulate human renal transporter alterations #NASH #AnimalModels #DrugTransporters
https://t.co/K9G5MuI7Bx

[Cherrington lab @Cherrington_Lab]

Lab participation on #SOT2023 undergrads and postdoc from the lab. #RenalToxicity #XenobioticTransporter #LiverDisease

[Cherrington lab @Cherrington_Lab]

New publication Alert: https://t.co/9PFAn15t4J

[Cherrington lab @Cherrington_Lab]

SWEHSC Delivers With Collaboration, Research Success https://t.co/3ANCzeKnsX

[Cherrington lab @Cherrington_Lab]

With my dear friend Dr. Smith #LightTheWorld #HappyHolidays2022

[Cherrington lab @Cherrington_Lab]

Ending the year with our #FirstAnnual #Pickleball #Tournament Congrats to the winning team, Paxton and Dominique!

[Cherrington lab @Cherrington_Lab]

#October is #BreastCancerAwareness month

[UA SWEHSC @UAZ_SWEHSC]

Thank you Linda Birnbaum, former @NIEHS director, for speaking with our community about PFAS at our Science Café this morning!

[Cherrington lab @Cherrington_Lab]

Congratulations, well deserved!

[UArizona R. Ken Coit College of Pharmacy @UAZPharmacy]

Congratulations Dr. Xinxin Ding on being elected Secretary/Treasurer of @ASPET!

“I am humbled to be elected to the ASPET council, and also excited to have the opportunity to contribute my ideas, diligence and experience to the continued success of ASPET”
-Dr. Xinxin Ding

[Cherrington lab @Cherrington_Lab]

Open access version is now available
https://t.co/GnwTVnWN2i

[Amgen 🧪🔬🧬 @Amgen]

Nearly 40% of Americans belong to a racial or ethnic minority, but individuals who participate in clinical trials skew heavily white—up to 80-90%. Ep. 3 of Innovating Clinical Trials is about strategies for better trial diversification. Tune in! https://t.co/S46KIHWqig